BTAI vs UAL · rev $388.0K vs P/E 10, rev $32.28B
BioXcel Therapeutics Inc (BTAI) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported UAL revenue for 2026-06-30 was $32.28B. Net income was $1.50B. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
BTAI currently screens at market cap $36.1M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the BTAI and UAL stock pages for the full models.
Not investment advice.